Hikma Pharmaceutical shares fall despite strong first half
Multinational pharmaceutical company Hikma Pharmaceutical (HIK) reported a strong first half with core revenues up 7% to $1.22 billion and core operating profit 15% higher at $309 million.However, the shares dropped 3.2% to £25.58...
06 August 2021